Aged Garlic Extract Suppresses the Development of Atherosclerosis in Apolipoprotein E-Knockout Mice

Naoaki Morihara1, Atsuko Hino2, Takako Yamaguchi3

  • 1Drug Discovery Laboratory and morihara_n@wakunaga.co.jp.

The Journal of Nutrition
|January 15, 2016
PubMed
Abstract

Insights

Aged garlic extract (AGE) reduces atherosclerosis in mice by inhibiting inflammation and lipid deposition. This study shows AGE significantly slows lesion progression and lowers cholesterol and triglycerides in ApoE-knockout mice.

Area of Science:

  • Cardiovascular Research
  • Nutraceuticals
  • Animal Models of Atherosclerosis

Background:

  • Aged garlic extract (AGE) is known to slow coronary calcification in patients with coronary artery disease.
  • The precise mechanisms by which AGE exerts its anti-atherosclerotic effects require further elucidation.

Purpose of the Study:

  • To investigate the potential of AGE in suppressing the formation and progression of atherosclerosis.
  • To clarify the underlying mechanisms of AGE's action in a relevant animal model.

Main Methods:

  • Apolipoprotein E-knockout (ApoE-KO) mice and wild-type controls were fed standard diets with or without 3% AGE for 12 or 24 weeks.
  • Serum lipid profiles (total cholesterol, triglycerides), aortic atherosclerotic lesion area, and splenic immune cell populations (monocytes/macrophages, T cells) were analyzed.

Main Results:

  • ApoE-KO mice exhibited significantly larger atherosclerotic lesions compared to controls.
  • AGE administration markedly inhibited lesion progression by 22% at 12 weeks and suppressed increases in serum total cholesterol and triglycerides.
  • AGE treatment also reduced the relative abundance of CD11b(+) monocytes/macrophages in ApoE-KO mice.

Conclusions:

  • Aged garlic extract demonstrates significant anti-atherosclerotic activity in ApoE-KO mice.
  • AGE's benefits appear to stem from the suppression of vascular inflammation and lipid deposition during early atherogenesis.